BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Orexigen Therapeutics, Inc. (OREX)'s Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) Receives Positive CHMP Opinion Recommending Approval For Weight Management In The European Union 12/19/2014 7:48:49 AM
Orexigen Therapeutics, Inc. (OREX) To Present At The Piper Jaffray Healthcare Conference 11/26/2014 10:18:37 AM
Orexigen Therapeutics, Inc. (OREX) Announces Allowance Of New U.S. Patent For Contrave (Naltrexone Hcl / Bupropion Hcl Extended Release) 11/21/2014 10:13:32 AM
Orexigen Therapeutics, Inc. (OREX) Reports Results For The Third Quarter Ended September 30, 2014 11/10/2014 8:46:48 AM
Orexigen Therapeutics, Inc. (OREX) To Present At The Credit Suisse Healthcare Conference 11/7/2014 8:22:33 AM
Orexigen Therapeutics, Inc. (OREX) To Host Third Quarter 2014 Financial Results Conference Call And Webcast 11/5/2014 7:51:18 AM
Orexigen Therapeutics, Inc. (OREX) Announces Contrave® (naltrexone HCI And Bupropion HCI Extended Release) Data Presentations At The ObesityWeek Meeting In Boston 10/31/2014 7:32:20 AM
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014 8:22:26 AM
Orexigen Therapeutics, Inc. (OREX) Pockets $100 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 10/15/2014 7:00:15 AM
Orexigen Therapeutics, Inc. (OREX) To Present At The Bank of America (BAC) Merrill Lynch Global Healthcare Conference 9/17/2014 8:06:03 AM
12345678910...